We report two cases of infection with clonally unrelated, high-level ciprofloxacin-resistant, β-lactamase–producing strains of
Ciprofloxacin, a member of the large and widely used fluoroquinolone group of antimicrobial drugs, is considered the empirical treatment of choice of gastrointestinal infections in adults. The fluoroquinolones have been licensed for use in humans as well as in food-producing animals. This use has raised a worldwide debate on the selection of fluoroquinolone-resistant bacteria in, and the possible circulation between, the different ecosystems concerned (
A 74-year-old man with an aorto-femoral bypass and chronic prostatitis became febrile and was treated empirically with ciprofloxacin. After 2 weeks of persistent fever, he was hospitalized. A pyelonephritis was diagnosed and endocarditis suspected. Urinalysis and blood culture both led to the isolation of a strain of
A 3-month-old boy (body weight 6 kg) arrived at the hospital with severe diarrhea and fever. A stool culture indicated a strain of
All STm strains were analyzed for their lysotype, pulsed-field gel electrophoretic (PFGE) pattern, and resistance phenotype and genotype, as previously described (
| Isolate | MIC (mg/L)a | |||
|---|---|---|---|---|
| NOR | CIPb | CTM | CTX | |
| NCTC
12416 | 0.06 | 0.016 | 0.06 | 0.125 |
| A | 32 | 16 | 0.06 | 0.06 |
| B1 | 32 | 32 | 0.25 | 0.125 |
| B2 | 32 | 32 | 1 | 0.25 |
| B3 | 32 | 32 | 1 | 0.25 |
| C | 32 | 32 | 0.25 | 0.125 |
aNOR, norfloxacin; CIP, ciprofloxacin; CTM, cefotaxime; CTX, ceftriaxone. bMICs of moxifloxacin were identical to those of CIP.
To identify mutations responsible for HLRC, the quinolone resistance determining regions (QRDR) of DNA gyrase and topoisomerase IV were determined after nucleotide sequencing of the corresponding QRDR fragments which were PCR-amplified with the respective pairs of primers: 5′CTGAAGCCGGTACACCGTCG and 5′TCGGCCATCAGTTCGTGGGC for
Electrophoretic (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) analysis of outer membrane proteins indicated the loss of one of them, possibly a porin (data not shown), in the post-treatment isolates STmB2 and STmB3. These changes did not influence the levels of fluoroquinolone resistance but were associated with reduced susceptibility to cefoxitin and cefotaxime (fourfold) and to ceftriaxone (twofold) (
The two cases reported here show that clonally unrelated HLRC strains of
Low-level ciprofloxacin resistance in salmonellae has been observed occasionally in the environment in France (
The unwelcome occurrence of fluoroquinolone-resistant salmonellae accumulating multiple mechanisms of resistance could compromise standard therapy of infections attributable to such pathogens. For children, an initial high-dose regimen with commonly used third-generation cephalosporins, or with oral cephalosporins, may therefore be indicated for the treatment of infections caused by
We gratefully acknowledge F. Grimont and F.X. Weill for lysotype determinations.
This work was supported in part by a grant from the Ministère de la Recherche et de la Technologie (Programme de Recherche Fondamentale en Microbiologie et Maladies Infectieuses et Parasitaires).
Dr. Casin is a medical microbiologist at the Hôpital Saint-Louis, a University Teaching Hospital in Paris, France. She works on various aspects of bacterial resistance to antimicrobial drugs in gram-negative bacteria, including molecular epidemiology and mechanisms.